Pregnancy
Conditions
Interventions
Case series:NA
Sponsors
Women's Hospital, School of Medicine, Zhejiang University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Pregnant women who are taking or have taken ribavirin in early pregnancy (including ribavirin alone or with other medicine in conbination treatment); 2. Pregnant women who have taken ribavirin 6 months before conception (including ribavirin alone, or with other medicine in conbination treatment); 3. Pregnant women who voluntarily participated in the survey with informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant women who don't know the dosage and time; 2. Pregnant women using ribavirin in the second and third trimester of pregnancy; 3. Pregnant women who cannot participate in the survey due to mental illness or physical disability.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| congenital defect; | — |
Secondary
| Measure | Time frame |
|---|---|
| spontaneous abortion;induced abortion;adverse events of fetus;premature labour;adverse events of neonatus;birth weight;Apgar scores;adverse events of infant;adverse events of children; | — |
Countries
China
Contacts
Public ContactCaihong Zheng
Women's Hospital, School of Medicine, Zhejiang University
Outcome results
None listed